Delphine Diagnostics is pleased to announce the appointment of Mr. Raj Devalapalli as Senior Strategic Advisor to the Founder & CEO.
A respected pharmaceutical industry veteran, Mr. Devalapalli brings decades of experience across multiple ventures, including more than 150 ANDA approvals and extensive expertise in strategic partnerships and business growth. He has been advising Delphine’s leadership over the past year, contributing to the company’s strategic direction.
Delphine Diagnostics looks forward to leveraging his experience and guidance as the company continues to advance innovative solutions in the life sciences sector.